Skin, Hair & Cosmetic — Category Comparisons
Published · Researched 2026-09-21
Skin, Hair & Cosmetic Peptides — Category Comparisons
Category: Skin, Hair & Cosmetic peptides · Research dates: 2026-09-20 (8 items) / 2026-09-21 (6 items) · Items: 14 · Images: 80 verified real photos
Per-category review
If you buy one cosmetic peptide story this year, make it the boring one. Across 14 items and 80 verified product photos, the pattern is embarrassingly consistent: the peptides with the loudest marketing ("Botox in a bottle," "lash growth," "hair regrowth") have the weakest isolated evidence, while the ones with the most honest communities (GHK-Cu, Matrixyl) are the ones whose fans will tell you the effect is subtle and possibly just hydration. Nobody in this track is selling medicine — everything here is a cosmetic ingredient — and the file set is admirably blunt about that.
Who should buy what: If you want the most-discussed, most professionally scrutinized cosmetic peptide, that is GHK-Cu (Tier 1) and Argireline (Tier 1) — both argued over by actual dermatologists, both available cheap (The Ordinary ~$10 for Argireline). If you want the safest-feeling mainstream moisturizer peptides, Matrixyl / Matrixyl 3000 / Palmitoyl Tripeptide-1 (Tier 2) live inside well-reviewed formulas and nobody reports drama. If you are shopping lash or hair serums, understand you are buying a formula, not an ingredient: Capixyl, Biotinoyl Tripeptide-1, and Myristoyl Pentapeptide-17 (all Tier 3) have real but modest community records — less shedding, better-looking lashes — and the honest forums (Tressless) will tell you these are not regrowth agents. Oligopeptide-1/EGF (Tier 3) gives the fastest visible cosmetic payoff (overnight hydration) wrapped in the biggest open scientific question (does a 53-amino-acid protein penetrate skin at all?). Nonapeptide-1 and Hexapeptide-11 (both Tier 3) are passengers inside good products; judge the product, not the peptide. Tripeptide-29 remains UNVALIDATED — included for comparison, low community signal.
Traps to avoid: (1) White-label lash serums with "YOUR BRAND"-grade packaging and identical growth claims — two such renders were rejected from this very research pass for failing the real-photography bar. Buy named products. (2) The "Botox in a bottle" frame — 25-year-old marketing that delivery science never caught up with; even Argireline's dermatologist fans don't claim Botox replacement. (3) Attributing a formula's effect to one INCI line — every lash, hair, and brightening review in this set is confounded by co-actives, and the honest sources say so. (4) Prestige pricing for commodity actives — $10 buys the reference Argireline; $150+ buys branding. (5) Marketplace counterfeit/fulfillment risk on viral hair serums (half-empty bottles, plain-water complaints in the Wellgrow Gold aggregation). (6) Growth-factor cosmetics during active cancer treatment — one reviewer-raised caution worth repeating: consult your oncology team.
Factual/spec table
| Item | Identity | INCI | CAS | Trade name / complex | Mechanism (as claimed) |
|---|---|---|---|---|---|
| Argireline | Acetyl Hexapeptide-8 | Acetyl Hexapeptide-8 | 616204-22-9 | Argireline® (Lipotec/Lubrizol, 2001) | SNAP-25 mimic → SNARE interference → reduced acetylcholine release (theoretical topical) |
| GHK-Cu | Glycyl-L-histidyl-L-lysine copper complex | Copper Tripeptide-1 | — | — | Copper delivery / skin-remodeling signaling |
| Matrixyl | Palmitoyl Pentapeptide-4 | Palmitoyl Pentapeptide-4 | — | Matrixyl® (Sederma) | Collagen-pathway signaling |
| Matrixyl 3000 | Palmitoyl Tripeptide-1 + Palmitoyl Tetrapeptide-7 | — (combo) | — | Matrixyl® 3000 (Sederma) | Dual collagen-pathway signaling |
| Palmitoyl Tripeptide-1 | Palmitoyl Tripeptide-1 | Palmitoyl Tripeptide-1 | — | — | Collagen-pathway signaling |
| Palmitoyl Tripeptide-38 | Palmitoyl Tripeptide-38 | Palmitoyl Tripeptide-38 | — | Matrixyl synthe'6® (Sederma) | Six matrix-component signaling |
| SNAP-8 | Acetyl Octapeptide-3 | Acetyl Octapeptide-3 | — | SNAP-8™ (Lipotec) | Extended SNAP-25 mimic, Argireline successor |
| Tripeptide-29 | Tripeptide-29 | Tripeptide-29 | — | — | — (UNVALIDATED, minimal data) |
| Nonapeptide-1 | Nonapeptide-1 (Melanostatine-5) | Nonapeptide-1 | UNVERIFIED | Melanostatine-5 | Melanin/tyrosinase-pathway brightening (as claimed) |
| Acetyl Tetrapeptide-3 | Acetyl Tetrapeptide-3 | Acetyl Tetrapeptide-3 | UNVERIFIED | Capixyl™ (Lucas Meyer) = peptide + red clover extract | Hair-follicle cosmetic signaling (as claimed) |
| Biotinoyl Tripeptide-1 | Biotinoyl Tripeptide-1 | Biotinoyl Tripeptide-1 | UNVERIFIED | Widelash™ (+ panthenol); Procapil™ (+ oleanolic acid, apigenin) | Lash/hair appearance support (as claimed) |
| Myristoyl Pentapeptide-17 | Myristoyl Pentapeptide-17 | Myristoyl Pentapeptide-17 | UNVERIFIED | SymPeptide XLash (Symrise) | Keratin-pathway lash support (as claimed) |
| Hexapeptide-11 | Hexapeptide-11 | Hexapeptide-11 | UNVERIFIED | — | Collagen/elastin-pathway support (as claimed) |
| Oligopeptide-1 | sh-Oligopeptide-1 = recombinant human EGF (53-aa protein) | Oligopeptide-1 | UNVERIFIED | — (BIOEFFECT barley EGF etc.) | EGF-receptor signaling; topical penetration debated |
Classification note: Every item in this track is a cosmetic ingredient. None is an FDA-approved drug, an injectable medicine, or a therapeutic product. Oligopeptide-1/EGF is a growth-factor protein, not a small peptide — the INCI name understates its size, and that distinction is load-bearing for the penetration debate.
Value comparison (dated prices, observed)
| Item | Cheapest honest entry found | Prestige / expensive end | Notes |
|---|---|---|---|
| Argireline | ~$9.21–$9.70, The Ordinary 30 ml (Amazon, 2026-09-20) | $154, PCA ExLinea Pro (IG, Nov 2025) | Same active, 15× spread — branding tax |
| GHK-Cu | — | — | — |
| Matrixyl | — (Cult Beauty verified-purchase reviews Jan–Feb 2026) | — | Affordable, gentle, subtle |
| Matrixyl 3000 | — | — | — |
| Palmitoyl Tripeptide-1 | — | — | — |
| Palmitoyl Tripeptide-38 | — | — | — |
| SNAP-8 | — | — | — |
| Tripeptide-29 | — | — | UNVALIDATED |
| Nonapeptide-1 | ~$9–$26.40 finished products (SkinSort, 2026-09-21) | $55, Biochem ampoule 30 ml (arwin.shop, 2026-09-21) | No standalone market |
| Acetyl Tetrapeptide-3 | ₹215 (~$2.50), MACARIA 60 ml (Myntra, 2026-09-21) | Western multi-peptide serums, several × more | Commodity complex, brand-priced |
| Biotinoyl Tripeptide-1 | £12, Aroma-Zone serum (Grazia, 2026) | $29.95, Bellahut raw Procapil (DIY) | Never sold standalone to consumers |
| Myristoyl Pentapeptide-17 | Drugstore lash serums | Prestige lash serums | Price is brand, not peptide |
| Hexapeptide-11 | Buried in $30–$64 moisturizers | £64, Pai Bonne Nuit (2026-09-21) | No standalone market |
| Oligopeptide-1 | K-beauty EGF ampoules (cheaper) | BIOEFFECT EGF Serum (prestige) | Exact prices not captured this pass — not invented |
No meaningful used market exists for any item; all are consumable cosmetics. FB Marketplace searches (2026-09-21): "lash serum" 3 listings (all unrelated), "EGF serum" 0, "hair growth serum" 2 (unrelated), "peptide serum" 1 (unrelated) — zero relevant listings.
Sentiment matrix
| Item | Tier | Community praise (recurring) | Community complaints (recurring) |
|---|---|---|---|
| Argireline | Tier 1 | Cheap experiment; subtle softening of expression lines | "Botox in a bottle" oversell; penetration skepticism; prestige price gouging |
| GHK-Cu | Tier 1 | Most professionally scrutinized; broad discussion | Debate over magnitude of effect |
| Matrixyl | Tier 2 | Reliable, gentle, affordable | Effect subtle, possibly hydration-driven |
| Matrixyl 3000 | Tier 2 | Long-term user testimony (neck/marionette lines) | Confounded by concurrent tretinoin |
| Palmitoyl Tripeptide-1 | Tier 2 | Strong social signal | No community-controlled evidence |
| Palmitoyl Tripeptide-38 | Tier 2 | Professional-channel endorsement | Commercial funnels behind the endorsements |
| SNAP-8 | Tier 2 | Real multi-platform discussion | Vendor-dominated; fewer independent professional voices |
| Tripeptide-29 | UNVALIDATED | — | Below Tier 3: minimal community signal |
| Nonapeptide-1 | Tier 3 | Gradual brightening; non-irritating | Slow (months); $55 questioned; no isolated evidence |
| Acetyl Tetrapeptide-3 | Tier 3 | Reduced shedding; better hair appearance; cheap (India) | No regrowth for androgenic alopecia; counterfeit/fulfillment complaints |
| Biotinoyl Tripeptide-1 | Tier 3 | Reduced shedding; £12 entry | No significant regrowth; oily feel/acne; attribution impossible |
| Myristoyl Pentapeptide-17 | Tier 3 | Lash condition/plumpness; some growth reports | Polarized outcomes; irritation minority; weak isolated evidence |
| Hexapeptide-11 | Tier 3 | Rides in well-reviewed moisturizers | No isolatable evidence; invisible in marketing |
| Oligopeptide-1 | Tier 3 | Overnight hydration/plumpness; brightening | No verifiable structural effect; penetration debate; oncology caution |
Use-case / risk matrix
| Use case | Best-fit items | Key risks / caveats |
|---|---|---|
| Expression-line softening (cosmetic) | Argireline, SNAP-8 | Not Botox; penetration debated; manage expectations |
| General anti-aging moisturizer peptide | Matrixyl, Matrixyl 3000, Palmitoyl Tripeptide-1/38, Hexapeptide-11 | Effects subtle; buy the formula, not the INCI line |
| Skin remodeling / copper peptide interest | GHK-Cu | Most debated; read the professional discourse first |
| Hair shedding / density appearance | Acetyl Tetrapeptide-3 (Capixyl), Biotinoyl Tripeptide-1 | Not regrowth agents; counterfeit risk on marketplaces; months for results |
| Lash/brow appearance | Myristoyl Pentapeptide-17, Biotinoyl Tripeptide-1 (Widelash) | Polarized outcomes; irritation possible; white-label minefield — buy named brands |
| Brightening / tone-evening | Nonapeptide-1 | Slow; expensive isolated SKUs; no isolated evidence |
| Premium hydration / post-procedure positioning | Oligopeptide-1 (EGF) | 53-aa penetration question; oncology-treatment caution; prestige pricing |
| Speculative / comparison only | Tripeptide-29 | UNVALIDATED — no community signal |
Takeaways
- The track splits into three evidence classes: professionally debated (Argireline, GHK-Cu — Tier 1), formula-embedded mainstream (Matrixyl family, SNAP-8 — Tier 2), and formula-confirmed but ingredient-invisible (the six recovered items — Tier 3) plus one UNVALIDATED.
- Attribution is the track's central unsolved problem. Every lash, hair, brightening, and moisturizer verdict is confounded by co-actives. The honest sources say so; the dishonest ones don't.
- Price spreads are branding, not chemistry. Argireline $10 vs $154; Capixyl ₹215 vs Western prestige multiples. The commodity/complex is the same.
- The hair-loss community is the most honest in the track. Tressless regulars grant Capixyl reduced shedding while refusing regrowth claims — a model for how to talk about cosmetic peptides.
- EGF is the interesting paradox: fastest visible cosmetic payoff, weakest mechanistic story (53 amino acids vs. the skin barrier), and the only item with a reviewer-raised medical caution.
- No dosing protocols exist or are implied anywhere in this track. These are cosmetics, not medicines, and the files are written that way.
Social pulse (track-level, 2026-09-20/21)
- Strongest professional scrutiny: Argireline (dermatologist IG bloc: Agarwal, Waldman, Locke, Roba, Goldman/MDedge) and GHK-Cu.
- Strongest owner-review volume: Matrixyl (Cult Beauty verified purchases), Capixyl (Tressless multi-year threads), lash serums (Ulta/NULASTIN polarized dataset), EGF (desertcart 389 reviews).
- Weakest signal: Tripeptide-29 (UNVALIDATED), Hexapeptide-11 (one zero-like brand post), Nonapeptide-1 (zero Meta-platform discussion found).
- Viral cycles: Argireline's 2026 K-beauty revival (Sungboon Editor "frozen forehead" → nurse fact-check → debunker wave). No other item had a viral moment.
- Sponsored/vendor contamination: Documented per item — Envii Labs (Capixyl, brand), Kosas (MP-17, brand), dadface.skin (Hexapeptide-11, brand), L.A. Colors/Toplash (Biotinoyl, promo), esthetician commercial funnels (Palmitoyl Tripeptide-38), Bellahut vendor-hosted reviews (Biotinoyl, not independent), buyerreview.com affiliate-style page (EGF, not independent).
Meta findings (Facebook / Instagram / Threads)
- Facebook Groups are the highest-signal layer by contract, but group post queries returned zero indexed hits for all six recovered items (and were thin for the earlier eight) — a search-index limitation of the available tooling, reported as observed rather than treated as proof of absence. This is the category's largest evidence gap, flagged on every dossier page.
- Threads produced directly observed, dated evidence: Envii Labs/Capixyl (brand, Aug 1 2026), @brute.choi/EGF (creator, Aug 30 2026), @gazelle.4770243/EGF (owner, Jul 11 2026), Kosas/MP-17 (brand, Aug 2025), dadface.skin/Hexapeptide-11 (brand, Sep 19 2026), L.A. Colors/Toplash promos (Biotinoyl). Owner/creator content was found only for EGF.
- Instagram: no independent owner content captured for the six recovered items this round; IG-attributable material is brand/retailer assets. (The earlier eight items had stronger IG layers — see their files.)
- Facebook Marketplace: zero relevant listings across "lash serum," "EGF serum," "hair growth serum," and "peptide serum" (2026-09-21) — consumable cosmetics have no used market.
Substitutions
None in this track. All 14 planned items were researched as briefed. Image-level substitutions only: two rejected renders (biotinoyl) and one duplicate view (myristoyl) were deleted rather than substituted; failed downloads (hexapeptide-11 detail) were disclosed, not silently replaced.
Caveats
- UNVERIFIED tags mark every sequence/CAS/price not confirmed against a primary source this round — concentrated in the six recovered items (sequences and CAS numbers) and scattered exact prices.
- UNVALIDATED: Tripeptide-29 — included for comparison, low community signal.
- Attribution caveat: no item file claims an ingredient-level effect from formula-level reviews; where a source states the caveat (abeautyedit, skincarmanyc), it is quoted.
- Promotional-bias caveats are attached to Practo Q&A, Bellahut on-site reviews, brand Threads posts, and affiliate-disclosed press.
- Regulatory: all 14 items are cosmetic ingredients; none is an FDA-approved drug; US cosmetics require no premarket approval provided sellers avoid drug claims. "Botox-like," "hair-loss treatment," and "lash growth" framings sit at or across that line.
Direct-source log (recovered six, 2026-09-21)
- Threads: @enviilabs (2026-08-01), @brute.choi (2026-08-30), @gazelle.4770243 (2026-07-11), Kosas brand (2025-08), @dadface.skin (2026-09-19), L.A. Colors (2024-08-16), Toplash promo (2026-09-19)
- Tressless: "Procapil, Capixl and Redensyl for combatting hair loss?" / The Ordinary Multi-Peptide Serum thread / Haircross serum thread / tressless.com/search/community/capixyl-peptide-complex/1
- Practo: "Is capixyl hair serum good?" (dermatologist answer)
- NCOA 2026 citing Int J Trichology 2025 (Redensyl/Procapil/Capixyl review)
- Retail: arwin.shop/desertcart (Biochem ampoule), Myntra/Macaria (2026-08-10 review), Flipkart/Intimify (109 ratings), Grazia Daily UK (Aroma-Zone £12), thepeachdiary.in (Minimalist 2023), bellahut.com (Procapil $29.95), wildnpretty (UKLASH), ulta.com (NULASTIN), abeautyedit (The Ordinary lash/brow), eyelashes.org (City Lash), toplash (brand blog), beautydecoded (Mádara), whatsinmyjar (Pai £64, So Natural, Farm Stay), skincarmanyc (Skinfix), skinsort.com (Nonapeptide-1 565 products; Hexapeptide-11 moisturizers), beautyincolor (BIOEFFECT), desertcart.es (FOREST OF THE BORGES 4.4★/389), adilsons.mu (APLB), stackedskincare, typology (Cosmetics 2025 YEN F.-L.), derma.pk (Follitin), Medium 2026 (The Ordinary guide), buyerreview.com (affiliate-style)
- Facebook: groups post queries (zero indexed hits), Marketplace searches (zero relevant listings) — facebook-cli, 2026-09-21
Report index
| # | Item | File | Tier | Images |
|---|---|---|---|---|
| 1 | Argireline (Acetyl Hexapeptide-8) | argireline | Tier 1 | 8 |
| 2 | GHK-Cu (Copper Tripeptide) | ghk-cu | Tier 1 | 6 |
| 3 | Matrixyl (Palmitoyl Pentapeptide-4) | matrixyl | Tier 2 | 5 |
| 4 | Matrixyl 3000 | matrixyl-3000 | Tier 2 | 5 |
| 5 | Palmitoyl Tripeptide-1 | palmitoyl-tripeptide-1 | Tier 2 | 6 |
| 6 | Palmitoyl Tripeptide-38 (Matrixyl synthe'6) | palmitoyl-tripeptide-38 | Tier 2 | 3 |
| 7 | SNAP-8 (Acetyl Octapeptide-3) | snap-8 | Tier 2 | 7 |
| 8 | Tripeptide-29 | tripeptide-29 | UNVALIDATED | 4 |
| 9 | Nonapeptide-1 (Melanostatine-5) | nonapeptide-1 | Tier 3 | 7 |
| 10 | Acetyl Tetrapeptide-3 (Capixyl) | acetyl-tetrapeptide-3 | Tier 3 | 6 |
| 11 | Biotinoyl Tripeptide-1 (Widelash/Procapil) | biotinoyl-tripeptide-1 | Tier 3 | 5 |
| 12 | Myristoyl Pentapeptide-17 (SymPeptide XLash) | myristoyl-pentapeptide-17 | Tier 3 | 7 |
| 13 | Hexapeptide-11 | hexapeptide-11 | Tier 3 | 5 |
| 14 | Oligopeptide-1 (EGF) | oligopeptide-1 | Tier 3 | 6 |
14 dossiers + this comparison. 80 verified real images, zero AI images.
Not medical advice. This is a research summary of public social and web sources, not a recommendation to buy or use any product. Cosmetic peptides are not medicines; consult a qualified clinician for skin or hair concerns.
Named sources
- Threads @brute.choi — @brute.choi/EGF (creator, Aug 30 2026) (Aug 30 2026)
- Threads @gazelle.4770243 — @gazelle.4770243/EGF (owner, Jul 11 2026) (Jul 11 2026)
- Threads @enviilabs — Threads: @enviilabs (2026-08-01) (2026-08-01)
- Threads @dadface.skin — @dadface.skin (2026-09-19) (2026-09-19)
- Kosas — MP-17, brand — - **Sponsored/vendor contamination:** Documented per item — Envii Labs (Capixyl, brand), Kosas (MP-17, brand), dadface.skin (Hexapeptide-11, brand), L.A. Colors
- Envii Labs — brand, Aug 1 2026 (Aug 1 2026)
- Capixyl — brand, Aug 1 2026 (Aug 1 2026)
- MP-17 — brand, Aug 2025 (Aug 2025)
- Myntra — 2026-08-10 review (2026-08-10)
- Macaria — 2026-08-10 review (2026-08-10)
- Flipkart — 109 ratings
- Intimify — 109 ratings
- Grazia Daily UK — Aroma-Zone £12 — - Retail: arwin.shop/desertcart (Biochem ampoule), Myntra/Macaria (2026-08-10 review), Flipkart/Intimify (109 ratings), Grazia Daily UK (Aroma-Zone £12), thepea
Source URLs were not recorded for these references.